Abstract
Malaria research has led to the discovery of oncofetal chondroitin sulfate, which appears to be shared between placental trophoblasts and cancer cells and can be detected by the evolutionary refined malaria protein VAR2CSA. Interestingly, using recombinant VAR2CSA to target oncofetal chondroitin sulfate shows promise for novel cancer diagnostics and therapeutics.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Trends in Parasitology |
Vol/bind | 35 |
Udgave nummer | 3 |
Sider (fra-til) | 178-181 |
ISSN | 1471-4922 |
DOI | |
Status | Udgivet - mar. 2019 |